APA

Groves H. E., Jenkins L., Macfarlane M., Reid A., Lynn F. & Shields M. D. (20161213). Efficacy and long-term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland. : Pediatric pulmonology.

Chicago

Groves H E, Jenkins L, Macfarlane M, Reid A, Lynn F and Shields M D. 20161213. Efficacy and long-term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland. : Pediatric pulmonology.

Harvard

Groves H. E., Jenkins L., Macfarlane M., Reid A., Lynn F. and Shields M. D. (20161213). Efficacy and long-term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland. : Pediatric pulmonology.

MLA

Groves H E, Jenkins L, Macfarlane M, Reid A, Lynn F and Shields M D. Efficacy and long-term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland. : Pediatric pulmonology. 20161213.